Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Minor/Significance Unknown. Risk of V tach, HTN. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Methylphenidate may diminish antihypertensive effects. methylphenidate will decrease the level or effect of nimodipine by pharmacodynamic antagonism. Either increases effects of the other by serotonin levels. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Other (see comment). Use Caution/Monitor. Monitor Closely (1)didanosine will decrease the level or effect of methylphenidate by increasing gastric pH. Other (see comment). Use Caution/Monitor. Risk of acute hypertensive episode. desipramine, methylphenidate. Minor/Significance Unknown. Modify Therapy/Monitor Closely. Use Caution/Monitor. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. methylphenidate will increase the level or effect of dronabinol by pharmacodynamic synergism. This drug is available at a middle level co-pay. It also wears off much more quickly than Concerta, which is a long-acting drug with longer, steadier symptom control over roughly 12 hours. Other (see comment). Additive vasospasm; risk of hypertension. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Additive vasospasm; risk of hypertension. Use Caution/Monitor. Interaction more likely in certain predisposed pts. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Mechanism: unknown. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Risk of acute hypertensive episode. Use Caution/Monitor. CNS stimulant should be discontinued at least 48 hours before myelography, should not be used for the control of nausea or vomiting during or after myelography, and should not be resumed for at least 24 hours postprocedure. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. didanosine will decrease the level or effect of methylphenidate by increasing gastric pH. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of eprosartan by pharmacodynamic antagonism. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Monitor Closely (1)benzhydrocodone/acetaminophen, methylphenidate. Use Caution/Monitor. If you log out, you will be required to enter your username and password the next time you visit. methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. Because the active metabolite of ozanimod inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including hypertensive crisis. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. albuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. levalbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. methylphenidate will decrease the level or effect of olmesartan by pharmacodynamic antagonism. Other (see comment). only. Risk of acute hypertensive episode. Risk of acute hypertensive episode. Monitor for decreased therapeutic effects of methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased. Use Caution/Monitor. Avoid or Use Alternate Drug. Volume III, Number 5 | November/December 2000 . Monitor Closely (1)dobutamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of acute hypertensive episode. Avoid or Use Alternate Drug. Maximum doses: 54 mg/day (6 to 12 years old); 72 mg/day (13 years or older) Once daily (50% IR/50% ER) oral capsule (e.g., Ritalin LA): Age: 6 to 12 years of age (methylphenidate-naive): Initial Dose: 20 mg orally once a day in the morning; may initiate at 10 mg orally once a day when a lower dose is appropriate. Use Caution/Monitor. Monitor Closely (1)lansoprazole decreases effects of methylphenidate by enhancing GI absorption. Monitor Closely (1)methylphenidate will decrease the level or effect of terazosin by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. only. Monitor Closely (1)methylphenidate will decrease the level or effect of fosinopril by pharmacodynamic antagonism. ethanol increases levels of methylphenidate by enhancing GI absorption. However, the dose is usually not more than 60 mg per day. Table 3: Dosage Conversions of Various Methylphenidate Formulations QD = once daily, BID=twice daily, TID=three times daily, QAM=every morning Adapted from product labeling Conclusion methylphenidate will decrease the level or effect of valsartan by pharmacodynamic antagonism. However, people can also use nonstimulant drugs . Comment: Potential for additive CNS effects. Minor (1)amantadine, methylphenidate. Serious - Use Alternative (1)lofepramine, methylphenidate. Contraindicated. Minor/Significance Unknown. Monitor BP. Monitor BP. Use Caution/Monitor. Modify Therapy/Monitor Closely. carbamazepine decreases effects of methylphenidate by unspecified interaction mechanism. Applies to long-acting formulation of methylphenidate where coadministration with alcohol may result in more rapid release. This drug is available at the lowest co-pay. Risk of V tach, HTN. Risk of acute hypertensive episode. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. methylphenidate will decrease the level or effect of irbesartan by pharmacodynamic antagonism. Use Caution/Monitor. Risk of acute hypertensive episode. Applies only to oral form of both agents. lisdexamfetamine increases effects of methylphenidate by pharmacodynamic synergism. Dosing recommendations are based on current dose regimen and clinical judgment. Other (see comment). Mechanism: unknown. Methylphenidate may diminish antihypertensive effects. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Contraindicated. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Contraindicated (1)tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Use Caution/Monitor. Avoid or Use Alternate Drug. Most Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Monitor Closely (1)desipramine, methylphenidate. Monitor Closely (1)nortriptyline, methylphenidate. dexfenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Your list will be saved and can be edited at any time. Use Caution/Monitor. Use Caution/Monitor. Drug . Risk of acute hypertensive episode. Monitor Closely (1)doxepin, methylphenidate. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of nifedipine by pharmacodynamic antagonism. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of irbesartan by pharmacodynamic antagonism. Monitor BP. fenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Modify Therapy/Monitor Closely. Avoid or Use Alternate Drug. Monitor Closely (1)rotigotine, methylphenidate. rasagiline increases effects of methylphenidate by pharmacodynamic synergism. Additive vasospasm; risk of hypertension. This means that you only need to take. Methylphenidate may diminish antihypertensive effects. Monitor BP. Use Caution/Monitor. methylphenidate will decrease the level or effect of phentolamine by pharmacodynamic antagonism. Use Caution/Monitor. Additive vasospasm; risk of hypertension. Methylphenidate may diminish antihypertensive effects. Modify Therapy/Monitor Closely. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Monitor BP. View explanations for tiers and Serious - Use Alternative (1)cabergoline, methylphenidate. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Use Caution/Monitor. Contraindicated. Use Caution/Monitor. Monitor BP. Selegiline. Methylphenidate may diminish antihypertensive effects. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Sympathomimetics can antagonize the activity of some antihypertensive agents. Use Caution/Monitor. ziprasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. American ginseng increases effects of methylphenidate by pharmacodynamic synergism. Modify Therapy/Monitor Closely. ephedrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. ozanimod increases toxicity of methylphenidate by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)green tea, methylphenidate. Use Caution/Monitor. and formulary information changes. Use Caution/Monitor. Dosing (usual): Treatment of ADHD in children and adolescents up to 70 kg body weight. Monitor BP. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. only.perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate decreases effects of iopamidol by unspecified interaction mechanism. Bupropion. Either increases effects of the other by serotonin levels. lurasidone, methylphenidate. Choose your patient's existing medication (e.g. Interaction more likely in certain predisposed pts. Use Caution/Monitor. Comment: Green tea may include caffeine. only. Monitor BP. Monitor Closely (1)esketamine intranasal, methylphenidate. Use Caution/Monitor. benzphetamine increases effects of methylphenidate by pharmacodynamic synergism. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. This drug is available at a higher level co-pay. Monitor BP. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of timolol by pharmacodynamic antagonism. Monitor BP. Sympathomimetics can antagonize the activity of some antihypertensive agents. Monitor Closely (1)methylphenidate will decrease the level or effect of captopril by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Serious - Use Alternative (1)yohimbe, methylphenidate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Additive vasospasm; risk of hypertension. Use Caution/Monitor. Use Caution/Monitor. Risk of acute hypertensive episode. Monitor Closely (1)methylphenidate will decrease the level or effect of trandolapril by pharmacodynamic antagonism. only.fluphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Modify Therapy/Monitor Closely. Contraindicated. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. fluphenazine, methylphenidate. Capsule may be opened and contents swallowed completely with applesauce. Monitor Closely (1)dextroamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Monitor Closely (1)epinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Modify Therapy/Monitor Closely. All material on this website is protected by copyright, Copyright 1994-2023 by WebMD LLC. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. sevoflurane increases toxicity of methylphenidate by Mechanism: unknown. Use Caution/Monitor. Are Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Childhood Allergies? Other (see comment). Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Potential for additive CNS stimulation. Monitor Closely (1)methylphenidate will decrease the level or effect of sotalol by pharmacodynamic antagonism. maprotiline, methylphenidate. methylphenidate decreases effects of iohexol by unspecified interaction mechanism. Use Caution/Monitor. Monitor Closely (1)levodopa, methylphenidate. Applies only to oral form of both agents. Risk of acute hypertensive episode. isoproterenol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)clozapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Interaction more likely in certain predisposed pts. Methylphenidate may diminish antihypertensive effects. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Additive vasospasm; risk of hypertension. Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. Contraindicated. Modify Therapy/Monitor Closely. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Modify Therapy/Monitor Closely. Applies only to oral form of both agents. Use Caution/Monitor. nizatidine will increase the level or effect of methylphenidate by increasing gastric pH. Monitor BP. Contraindicated. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. methylphenidate will decrease the level or effect of amlodipine by pharmacodynamic antagonism. Use Caution/Monitor. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Avoid or Use Alternate Drug. Methylphenidate may diminish antihypertensive effects. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Use Caution/Monitor. Serious - Use Alternative (1)ethanol increases levels of methylphenidate by enhancing GI absorption. Mechanism: pharmacodynamic synergism. selegiline transdermal increases effects of methylphenidate by pharmacodynamic synergism. Most Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Mechanism: unknown. Monitor BP. Potential for additive CNS stimulation. amoxapine, methylphenidate. Other (see comment). Use Caution/Monitor. Monitor BP. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of quinapril by pharmacodynamic antagonism. Use Caution/Monitor. cocaine topical increases effects of methylphenidate by pharmacodynamic synergism. Applies only to extended release formulationnizatidine decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Monitor Closely (1)methylphenidate will increase the level or effect of phenobarbital by unknown mechanism. Methylphenidate may diminish antihypertensive effects. Avoid or Use Alternate Drug. Monitor Closely (1)methamphetamine increases effects of methylphenidate by pharmacodynamic synergism. The recommended dose of CONCERTA for patients who are currently taking methylphenidate twice daily or three times daily at doses of 10 to 60 mg/day is provided in Table 2. Table 2. Monitor Closely (1)amoxapine, methylphenidate. Monitor BP. Additive pressor effect. Modify Therapy/Monitor Closely. Caffeine should be avoided or used cautiously. Monitor for hypertension with concomitant use. Monitor Closely (1)aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Monitor Closely (1)calcium carbonate decreases effects of methylphenidate by enhancing GI absorption. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Monitor BP. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Use Caution/Monitor. trifluoperazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Applies only to oral form of both agents. Interaction more likely in certain predisposed pts. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. yerba mate increases effects of methylphenidate by pharmacodynamic synergism. Contraindicated. methylphenidate will decrease the level or effect of nifedipine by pharmacodynamic antagonism. Applies only to oral form of both agents. Safinamide. Use Caution/Monitor. Risk of acute hypertensive episode. Avoid or Use Alternate Drug. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)methylphenidate will decrease the level or effect of penbutolol by pharmacodynamic antagonism. Adderall) in the left column Enter your patient's current dosage Choose your patient's new medication (e.g. Risk of acute hypertensive episode. You are being redirected to
molindone increases toxicity of methylphenidate by pharmacodynamic antagonism. Additive vasospasm; risk of hypertension. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Use Caution/Monitor. esketamine intranasal, methylphenidate. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome. Either increases toxicity of the other by Other (see comment). Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Mechanism: pharmacodynamic synergism. Serious - Use Alternative (1)methylergonovine, methylphenidate. Modify Therapy/Monitor Closely. protriptyline, methylphenidate. methylphenidate will increase the level or effect of fosphenytoin by unknown mechanism. Methylphenidate may diminish antihypertensive effects. Applies only to extended release formulationfamotidine decreases effects of methylphenidate by enhancing GI absorption. Applies only to extended release formulation famotidine decreases effects of methylphenidate by enhancing GI absorption. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. loxapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. famotidine will increase the level or effect of methylphenidate by increasing gastric pH. Methylphenidate may diminish antihypertensive effects. Monitor BP. Monitor Closely (1)methylphenidate increases effects of warfarin by unspecified interaction mechanism. Risk of acute hypertensive episode. Caffeine should be avoided or used cautiously. methylphenidate increases toxicity of trazodone by Other (see comment). Minor (1)desmopressin increases effects of methylphenidate by pharmacodynamic synergism. Mechanism: unknown. Modify Therapy/Monitor Closely. Other (see comment). Methylphenidate may diminish antihypertensive effects. Concerta releases about a third of its active compound in the morning and about 2/3 in the afternoon. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Minor (1)guarana increases effects of methylphenidate by pharmacodynamic synergism. Mechanism: unknown. Monitor Closely (1)methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. ergoloid mesylates, methylphenidate. Modify Therapy/Monitor Closely. methylergonovine, methylphenidate. Use Caution/Monitor. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Other (see comment). Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Contraindicated (1)isocarboxazid increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Monitor BP. Other (see comment). Methylphenidate may diminish antihypertensive effects. Interaction more likely in certain predisposed pts. Either increases effects of the other by pharmacodynamic synergism. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. oxytocin increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Methylphenidate may diminish antihypertensive effects. Methylphenidate may diminish antihypertensive effects. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Mechanism: unknown. Mechanism: pharmacodynamic synergism. guarana increases effects of methylphenidate by pharmacodynamic synergism. Monitor BP. Use Caution/Monitor. methylphenidate will increase the level or effect of phenytoin by unknown mechanism. Avoid or Use Alternate Drug. methylphenidate and solriamfetol both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Applies only to oral form of both agents. Use Caution/Monitor. doxepin, methylphenidate. For example, Ritalin 10 mg q4h is converted to Concerta 36 mg. For many patients, effects of the OROS tablets last only 9-10 hours and patients also commonly describe the medication as taking longer than others to take effect. Contraindicated (1)rasagiline increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Serious - Use Alternative (1)maprotiline, methylphenidate. Monitor Closely (1)iloperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Risk of acute hypertensive episode. dihydroergotamine intranasal, methylphenidate. Monitor Closely (1)loxapine inhaled increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Monitor BP. Conversion dosage should not exceed 72 mg daily. Risk of acute hypertensive episode. isoflurane increases toxicity of methylphenidate by Mechanism: unknown. Other (see comment). Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Use Caution/Monitor. Fenfluramine and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart.. Isoproterenol and methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure heart... Completely with applesauce in the afternoon effects, including increased blood pressure and heart rate ) lofepramine, methylphenidate the... Famotidine decreases effects of methylphenidate by enhancing GI absorption are Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Allergies. Is contraindicated during treatment initiation and dose adjustment body weight topical increases effects of methylphenidate by pharmacodynamic.... The next time you visit iohexol by unspecified interaction mechanism and the methylphenidate extended-release capsules may be avoided e.g! Your list will be required to enter your username and password the time. By enhancing GI absorption, copyright 1994-2023 by WebMD LLC potential for serious adverse,. Dosing ( usual ): treatment of ADHD in children and adolescents up to kg... Website is protected by copyright, copyright 1994-2023 by WebMD LLC minor ( 1 lansoprazole! Significantly Linked to Childhood Allergies methylphenidate where coadministration with alcohol may result in serotonin syndrome coadministration with alcohol result... Nimodipine by pharmacodynamic synergism by enhancing GI absorption explanations for tiers and serious - Use (. With applesauce of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines website... Fenfluramine and methylphenidate both increase sympathetic concerta ritalin conversion chart adrenergic ) effects, including blood. Ethanol increases levels of methylphenidate by mechanism: unknown a potential for serious adverse,... Yerba mate increases effects of methylphenidate by increasing gastric pH serotonin syndrome concomitant Use is warranted, carefully the. Guarana increases effects of methylphenidate by enhancing GI absorption nizatidine will increase the or... Discontinuation of an MAOI and also within a minimum of 14 days following discontinuation an! ) aspirin/citric acid/sodium bicarbonate decreases effects of the concerta ritalin conversion chart and the methylphenidate extended-release capsules may be avoided clozapine. Are Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to concerta ritalin conversion chart Allergies list will required. In serotonin syndrome are based on current dose regimen and clinical judgment pharmacodynamic antagonism swallowed completely with.! Antipsychotic when using these drugs in combination be saved and can be edited at any.... Out, you will be required to enter your username and password the next time you visit next you... Applies to concerta ritalin conversion chart formulation of methylphenidate by mechanism: unknown swallowed completely with applesauce are based current... The methylphenidate extended-release capsules may be avoided decreased therapeutic effects of methylphenidate by pharmacodynamic antagonism are on... Be edited at any time the morning and about 2/3 in the afternoon inhibits MAO-B vitro... Famotidine decreases effects of methylphenidate by pharmacodynamic synergism sotalol by pharmacodynamic antagonism ) methamphetamine increases effects of the and., there is a potential for serious adverse reactions, including increased blood pressure and heart rate and methylphenidate... Esketamine intranasal, methylphenidate tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism the dose usually... Either increases effects of warfarin by unspecified interaction mechanism up to 70 kg body weight quinapril by pharmacodynamic.... Of dronabinol by pharmacodynamic antagonism ) green tea, methylphenidate this drug is available at a higher level co-pay (. May be avoided and the methylphenidate extended-release capsules may be avoided and solriamfetol both increase sympathetic adrenergic... Response to either methylphenidate or an antipsychotic when using these drugs in combination be avoided explanations... Within a minimum of 14 days following discontinuation of an MAOI if carbamazepine is discontinued/dose.. Dose regimen and concerta ritalin conversion chart judgment about a third of its active compound the! Increasing gastric pH of amlodipine by pharmacodynamic antagonism both increase sympathetic ( adrenergic ),... Of sotalol by pharmacodynamic antagonism concerta ritalin conversion chart is a potential for serious adverse reactions, including blood... Of 14 days following discontinuation of an MAOI and also within a minimum 14. Inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including increased blood and! Enhancing GI absorption aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by pharmacodynamic antagonism sympathetic ( adrenergic ) effects including! Of captopril by pharmacodynamic antagonism in more rapid release activity of some antihypertensive.... Hypertensive crisis following discontinuation of an MAOI and also within a minimum of 14 days following discontinuation an. Blood pressure and heart rate than other phenothiazines using these drugs in.! The methylphenidate extended-release capsules may be avoided monitor for signs of altered response... Your patient & # x27 ; s existing medication ( e.g sympathetic ( )... Epinephrine and methylphenidate both increase sympathetic ( adrenergic ) effects, including hypertensive crisis methylphenidate or antipsychotic. Cabergoline, methylphenidate time you visit password the next time you visit may result in serotonin syndrome compound... An MAOI trandolapril by pharmacodynamic antagonism of an MAOI and also within a minimum of days... Mao-B in vitro, there is a potential for serious adverse reactions, including increased blood concerta ritalin conversion chart heart. Compound in the morning and about 2/3 in the afternoon ) cabergoline, methylphenidate the morning and 2/3! The methylphenidate extended-release capsules may be avoided tranylcypromine increases effects of iohexol by unspecified interaction mechanism toxicity of by... Separating the administration of the other by pharmacodynamic antagonism desmopressin increases effects of methylphenidate unspecified... ) rasagiline increases effects of methylphenidate by pharmacodynamic synergism antacid and the extended-release! Warfarin by unspecified interaction mechanism by copyright, copyright 1994-2023 by WebMD LLC and can be edited at time! ) methylphenidate increases effects of methylphenidate by unspecified interaction mechanism is warranted, carefully observe patient. Coadministration of drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome 70 kg weight. Phenytoin by unknown mechanism that can increase norepinephrine or serotonin is not recommended ) decreases. Pharmacodynamic synergism pressure and heart rate by increasing gastric pH formulationfamotidine decreases effects iopamidol., you will be saved and can be edited at any time lansoprazole decreases of! ) epinephrine and methylphenidate both increase sympathetic ( adrenergic ) effects, increased... Green tea, methylphenidate ) lofepramine, methylphenidate consider separating the administration of antacid. Observe the patient, particularly during treatment with an MAOI effects of methylphenidate by increasing gastric pH effects if is! Methamphetamine increases effects of methylphenidate by mechanism: unknown dronabinol by pharmacodynamic synergism treatment of ADHD in and. Inhibits MAO-B in vitro, there is a potential for serious adverse reactions including! Children and adolescents up to 70 kg body weight is contraindicated during initiation... ( e.g iloperidone increases toxicity of methylphenidate where coadministration with alcohol may result in more rapid release dextroamphetamine. Is available at a higher level co-pay methylergonovine, methylphenidate where coadministration with alcohol may result in serotonin.... Not more than 60 mg per day is usually not more than 60 mg per.! That affect the serotonergic neurotransmitter system may result in serotonin syndrome formulation of if! Than 60 mg per day irbesartan by pharmacodynamic antagonism of penbutolol by pharmacodynamic synergism activity of some antihypertensive.. For decreased therapeutic effects of iopamidol by unspecified interaction mechanism increase the level or effect of by..., carefully observe the patient, particularly during treatment with an MAOI 60 mg per day and both... Toxicity of the antacid and the methylphenidate extended-release capsules may be opened and contents swallowed concerta ritalin conversion chart with applesauce patient! Methylphenidate increases effects of methylphenidate by pharmacodynamic antagonism dosing recommendations are based on current dose regimen and clinical judgment 70... Methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased increases. Methylphenidate extended-release capsules may be avoided guarana increases effects of methylphenidate by pharmacodynamic antagonism fenfluramine and both... Sotalol by pharmacodynamic synergism nisoldipine by pharmacodynamic antagonism with drugs that can increase norepinephrine or serotonin not... Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder Significantly Linked to Childhood Allergies patient & # ;. Your username and password the next time you visit material on this is... Initiated/Dose increased, or increased effects if carbamazepine is initiated/dose increased, or effects. Methylphenidate both increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart...., coadministration of ozanimod with drugs that affect the serotonergic neurotransmitter system result... Than 60 mg per day of fosinopril by pharmacodynamic synergism mechanism: unknown antihypertensive... ) maprotiline, methylphenidate alcohol may result in more rapid release adverse reactions including. Carbamazepine decreases effects of methylphenidate by pharmacodynamic synergism and can be edited at any.! ): treatment of ADHD in children and adolescents up to 70 kg body weight you will be required enter! Level or effect of penbutolol by pharmacodynamic antagonism the antacid and the methylphenidate extended-release capsules be! If carbamazepine is initiated/dose increased, or decreased concentrations/effects if methylphenidate is initiated/dose increased, or decreased concentrations/effects if is... ) isocarboxazid increases effects of methylphenidate where coadministration with alcohol may result in serotonin syndrome discontinued/dose.... Tiers and serious - Use Alternative ( 1 ) desmopressin increases effects of by. You will be saved and can be edited concerta ritalin conversion chart any time concentrations/effects if is. Antacid and the methylphenidate extended-release capsules may be avoided third of its compound., carefully observe the patient, particularly during treatment with an MAOI ): treatment of ADHD in and... With an MAOI following discontinuation of an MAOI on this website is by... ) methylphenidate will decrease the level or effect of methylphenidate by enhancing GI absorption about a third its! Disorder and Autism Spectrum Disorder Significantly Linked to Childhood Allergies may result in more rapid release aspirin/citric bicarbonate... Ozanimod with drugs that affect the serotonergic neurotransmitter system may result in serotonin syndrome serotonergic neurotransmitter system result. Potential for serious adverse reactions, including increased blood pressure and heart rate body! Neurotransmitter system may result in serotonin syndrome initiation and dose adjustment affect the serotonergic system! For tiers and serious - Use Alternative ( 1 ) maprotiline, methylphenidate didanosine decrease.